Behrenbruch Christian 4

4 · Telix Pharmaceuticals Ltd · Filed May 6, 2026

AI-generated summary of this filing

Updated May 7, 2026

Telix (TLX) CEO Christian Behrenbruch Buys 67,935 Shares

What Happened

Christian Behrenbruch, MD & Group CEO and Director of Telix Pharmaceuticals (TLX), acquired a total of 67,935 ordinary shares in two open-market purchases on April 28–29, 2026.
Transactions: 34,500 shares at an average A$14.48 (A$499,560) on Apr 28; 33,435 shares at an average A$14.87 (A$497,178) on Apr 29. Total consideration reported: A$996,738. These were purchases (a cash buy, commonly viewed as a positive/accumulative action rather than a sale).

Key Details

Transaction dates and reported prices:
- 2026-04-28: 34,500 shares at reported avg A$14.48 (footnote F1: actual trades ranged A$14.42–A$14.58).
- 2026-04-29: 33,435 shares at reported avg A$14.87 (footnote F4: actual trades ranged A$14.54–A$14.72).
Currency: Purchase prices reported in Australian Dollars (A$) (footnote F2).
Ownership after transaction: Not specified in the provided filing excerpt.
Related party note: Footnote F3 states Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd (disclosure of related entity).
Timeliness: The Form 4 was filed on 2026-05-06 for transactions on 2026-04-28/29 — the filing was late (reported several days after the trades).

Context

These were straightforward open-market purchases (transaction code P). Purchases by a CEO can be of interest to retail investors as an indication of the insider acquiring shares, but filings don’t explain motivation.
Footnotes indicate the reported column prices are averages and the filer offers to provide a full breakdown of the per-trade prices within the stated ranges on request.

Form 4

Period: 2026-04-28

DirectorMD & Group CEO

Transactions

Purchase
Ordinary Shares
[F1][F2][F3]
2026-04-28$14.48/sh+34,500$499,560→ 20,709,500 total(indirect: Elk River Holdings Pty Ltd)
Purchase
Ordinary Shares
[F2][F4][F3]
2026-04-29$14.87/sh+33,435$497,178→ 20,742,935 total(indirect: Elk River Holdings Pty Ltd)

Footnotes (4)

[F1]The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.42 - $14.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
[F2]The purchase prices are reported in Australian Dollars.
[F3]Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd.
[F4]The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.54 - $14.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4.

Signature

/s/ Oliver Newman, on behalf of Dr. Christian Behrenbruch, MD & Group CEO|2026-05-06

1 file